<DOC>
	<DOCNO>NCT01699074</DOCNO>
	<brief_summary>The study Phase-I like double blind randomize placebo control crossover design trial . The objective ass dose response relationship glycemic vascular effect acutely administered Korean White Ginseng ( KWG ) ( Panax C.A . Meyer ) individual metabolic syndrome type 2 diabetes . Twenty seven subject Type 2 Diabetes ( Key inclusion criterion : HbA1c ≤8.5 % ) metabolic syndrome ( Key inclusion criterion : define The US National Cholesterol Education Program Adult Treatment Panel III ) recruit study .</brief_summary>
	<brief_title>Acute Dose Response Korean White Ginseng Metabolic Syndrome Type 2 Diabetes</brief_title>
	<detailed_description>This study hypothesize KWG dose dependently low postprandial area curve compare negative control , well dose dependently decrease postprandial glycemia . It also assume use KWG dose dependently decrease aortic brachial blood pressure , aortic augmentation index , mean arterial pressure , improve leave ventricular ejection duration ( ED ) subendocardial viability ratio ( SEVR ) compare control . Finally , expect notice effect subjective satiety level significant adverse effect compare control .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Men woman 1875 year old BMI 2535 kg/m2 Presence type 2 diabetes ( define HbA1c ≤8.5 % ) , treatment diet oral hypoglycemic medication ) OR Presence Metabolic Syndrome define The US National Cholesterol Education Program Adult Treatment Panel III ( NCEP III ) . As per NCEP III criterion , least three follow must present : central obesity : waist circumference ≥ 102 cm 40 inch ( male ) , ≥ 88 cm 36 inch ( female ) dyslipidemia : TG ≥ 1.7 mmol/L ( 150 mg/dl ) ; dyslipidemia : HDLC &lt; 40 mg/dL ( male ) , &lt; 50 mg/dL ( female ) blood pressure ≥ 130/85 mmHg ; fast plasma glucose ≥ 6.1 mmol/L ( 110 mg/dl ) BMI &gt; 35 kg/m2 Hypertensive ( brachial systolic BP ≥140mmHg and/or diastolic BP ≥90mmHg ) Pregnant woman , risk pregnancy , breastfeed time study . Women childbearing age use acceptable method birth control ( ie . abstinence , implant , injectables , oral contraceptive , IUDs etc ) . Chronic condition include : liver disease , cancer , heavy alcohol use , bleed disorder , history angina , congestive heart failure , coronary revascularization , peripheral vascular disease , retinopathy , kidney disease coronary/cerebrovascular event ; chronic use medication include bloodthinners , SSRIs , MAO inhibitor , medication affect NO synthesis ( eg . Viagra ) Allergy sensitivity placebo ( wheat bran ) , ginseng gelatin use capsule . Use ginseng product within three day precede study study . Allergies Panax specie , constituent member Araliaceae family . The use additional NHPs may affect blood pressure blood glucose Individuals suffer glucosegalactose malabsorption syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Korean White Ginseng</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Metabolic syndrome</keyword>
</DOC>